Olcegepant
Olcegepant (INN, code name BIBN-4096BS) is a calcitonin gene-related peptide receptor antagonist being studied as a potential treatment for migraines. A 2013 meta-analysis found olcegepant and telcagepant were effective and safe compared to placebo. See also * Telcagepant Telcagepant (INN) (code name MK-0974) is a calcitonin gene-related peptide receptor antagonist which was an investigational drug for the acute treatment and prevention of migraine, developed by Merck & Co. In the acute treatment of migraine, ... References Amines Antimigraine drugs Carboxamides Organobromides Piperazines Piperidines 4-Pyridyl compounds Quinazolines Calcitonin gene-related peptide receptor antagonists {{nervous-system-drug-stub ...
[...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]